Early bird registration is open and closes May 2025. Register now

  • 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

What makes Etanercept biosimilar a trusted choice in clinical practice?

Synopsis:

Information coming soon

Food inclusions:

TBA

Agenda:

Chairperson/s: Prof. Hoon-Suk Cha and Prof. Kunihiro Yamaoka
TBA mins
Welcome Remarks: Introduction
TBA mins
Etanercept: A pillar of RA Therapy with Proven Safety and Long-term Data
Prof. Yeon-Ah Lee
TBA mins
Review of Biosimilar Trials and Real-world Practice in Japan
Prof. Masayoshi Harigai
TBA mins
History of Eucept(Etanercept) – Beyond the Similar
Jungeun Park
TBA mins
Closing Remarks: Q&A and Discussion
All

Share

Key dates

Registrations
Abstracts